ATRC NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

AtriCure Inc · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data Download investor PDF
Latest close 35.04 USD
0.3% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 10.2% above the Trend Line and sits at 54.3% of its 52-week range. The latest completed week returned 0.3%, after a 16.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. Options positioning is bullish with 58/100 conviction, while the latest news-sentiment score is 59/100. Near-term considerations: earnings are due in 5d.

Setup score 52 out of 100
Latest Close 35.04 USD 24 Jul 2026
1W Return 0.3% latest completed week
4W Return 16.1% short-term follow-through
12W Return 20.7% quarterly tape
Trend Breadth 42.3% 22 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.3% Latest completed week; four-week move 16.1%. Indicator stack 23/86 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 58/100 conviction; expected move 10.0%. News sentiment 59/100 57 relevant articles in the latest sentiment read. Event risk 5d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 10.2% above the Trend Line and sits at 54.3% of its 52-week range. The latest completed week returned 0.3%, after a 16.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3012-week average 0.14

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.30Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 16.1% over four weeks, 20.7% over 12 weeks, and 11.2% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.3%
4W16.1%
12W20.7%
26W-10.3%
52W11.2%
Active trend streak0 weeks
Active weeks in one year22
Trend breadth42.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.20Latest activity-pressure read.
Pressure change181.6%Four-week change in activity pressure.
Leadership-5.60Latest relative-leadership reading.
RS change74.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 97% Model confidence 97%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength10/100Blend of value, momentum, and quality. Underlying universe rank 91; rank 1 is best.
Value4/100Relative valuation strength. Underlying universe rank 97; rank 1 is best.
Quality70/100Profitability and accounting quality. Underlying universe rank 31; rank 1 is best.
Momentum31/100Medium-term price momentum. Underlying universe rank 70; rank 1 is best.
Growth74/100Revenue and earnings growth. Underlying universe rank 27; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework4/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
168.2x
Price divided by trailing earnings.
Price / sales
3.1x
Market value relative to trailing revenue.
EV / EBITDA
61.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
76.2%
Gross profit retained from each unit of revenue.
Operating margin
3.0%
Operating profit retained from revenue.
Free-cash-flow margin
11.7%
Free cash flow generated from revenue.
Return on invested capital
3.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
13.9%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.0%
Cash dividends relative to market value.
Buyback yield
0.6%
Net share repurchases relative to market value.
Shareholder yield
0.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-3.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

ATRC shows bullish options pressure with a 58/100 conviction score, put-call volume ratio of 0.00, expected move of 10.0%, and Sharemaestro trend signal inactive.

Conviction58/100
Expected move10.0%
Put/call volume0.00
Pressure100
Speculation43
Volatility68
Trend agreement0
Open options detail
Insider activity13 / 2

13 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment59/100

Weighted news tone is neutral across 57 relevant articles.

26 positive · 28 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings5dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move10.0%Nearest-chain priced movement where available.
52-week drawdown-18.9%Distance below the 52-week high.
13-week volatility4.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+7.8%Week of 10 Jul.
Worst week-12.0%Week of 13 Feb.
Latest week+0.3%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains6
Flat weeks0
Modest losses10
Sharp losses4
Recent vol4.6%13-week weekly-return volatility.
Base vol4.8%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew4.1% / -3.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape44/100

Trend, activity pressure, participation, and risk combine to a 44/100 tape read.

 Indicator analysis24/100

Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.

Activity pressure 0.30; No reversal markers Factors28/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 34; Small Cap Core rank 97 SVQF4/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 697.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options50/100

ATRC shows bullish options pressure with a 58/100 conviction score, put-call volume ratio of 0.00, expected move of 10.0%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 10.0% Sentiment59/100

Weighted news tone is neutral across 57 relevant articles.

[10-Q] AtriCure, Inc. Quarterly Earnings Report Insiders13 / 2

13 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings5d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202635.04 USD0.3%31.80 USD32.98 USD1.20-5.605.2MOff
17 Jul 202634.95 USD2.0%31.97 USD33.11 USD1.11-7.503.7MOff
10 Jul 202634.28 USD7.8%32.17 USD33.23 USD0.96-13.113.9MOff
3 Jul 202631.79 USD5.3%32.44 USD33.35 USD0.78-18.205.8MOff
26 Jun 202630.18 USD4.8%32.71 USD33.45 USD0.42-22.036.2MOff
19 Jun 202628.80 USD0.0%32.91 USD33.58 USD0.16-29.354.1MOff
12 Jun 202628.79 USD6.2%33.16 USD33.70 USD-0.02-28.013.7MOff
5 Jun 202627.10 USD-2.1%33.29 USD33.82 USD-0.26-31.163.4MOff
29 May 202627.67 USD-2.2%33.46 USD33.95 USD-0.43-33.514.0MOff
22 May 202628.29 USD0.6%33.69 USD34.07 USD-0.63-30.753.7MOff
15 May 202628.12 USD7.0%34.00 USD34.19 USD-0.78-30.914.0MOff
8 May 202626.28 USD-9.4%34.30 USD34.32 USD-0.89-36.145.9MOff
1 May 202629.02 USD-0.9%34.63 USD34.46 USD-0.97-26.264.1MOff
24 Apr 202629.28 USD-1.5%34.82 USD34.59 USD-1.09-24.914.5MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.